SOPHiA GENETICS
SOPHiA GENETICS is a Swiss healthcare technology company advancing data-driven medicine through artificial intelligence and genomic data analysis. Founded in 2011 and headquartered in Rolle, Switzerland, the company developed SOPHiA DDM, a cloud-based platform that analyzes complex next-generation sequencing (NGS) and multimodal data to support clinical decision-making in oncology, hereditary cancers, and rare inherited disorders. Trusted by more than 1,000 hospitals, laboratories, and biopharma institutions across 70+ countries, the platform delivers standardized variant detection, radiomics, and multimodal analytics while keeping data decentralized. With millions of genomic profiles analyzed, SOPHiA GENETICS helps democratize access to precision medicine and improve patient outcomes worldwide.
Danyel Biotech is the exclusive distributor of SOPHiA GENETICS in Israel, providing local sales, technical service, and application support.
- Clinical Bioinformatics
- NGS Data Analysis
- Precision Medicine
ISO 13485, ISO/IEC 27001:2022, ISO/IEC 27017:2015, ISO/IEC 27018:2019, CE-IVD (DDM Dx solutions), IVDR compliance, HIPAA & GDPR compliant
Frequently Asked Questions
Who is the official SOPHiA GENETICS distributor in Israel?
Danyel Biotech is the official distributor of SOPHiA GENETICS in Israel, providing sales, local service and application support.
Where can I buy AI-driven clinical NGS data analysis in Israel?
Danyel Biotech supplies SOPHiA GENETICS AI-driven clinical NGS data analysis in Israel, with local stock, installation and technical support.